Cargando…

COVID-19 in patients with rheumatic disease: finally, a denominator

Detalles Bibliográficos
Autor principal:	Wallace, Daniel J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081402/ https://www.ncbi.nlm.nih.gov/pubmed/33942032 http://dx.doi.org/10.1016/S2665-9913(21)00121-1

Ejemplares similares

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
por: Sen, Parikshit, et al.
Publicado: (2023)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea
por: Schreiber, Karen, et al.
Publicado: (2021)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

Importance of nociplastic pain in patients with rheumatic diseases
por: Alcántara Montero, Antonio
Publicado: (2023)

Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries
por: El Kibbi, Lina, et al.
Publicado: (2022)

Uncommon Denominators
por: Potter, Polyxeni
Publicado: (2007)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Considering Research Denominators
por: Fetzer, Susan J.
Publicado: (2020)

Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Shenoy, Padmanabha, et al.
Publicado: (2022)

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
por: Gao, Xing-Su, et al.
Publicado: (2022)

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Price-Denomination Effect: Choosing to Pay With Denominations That Are the Same as the Product Prices
por: Reutskaja, Elena, et al.
Publicado: (2020)

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
por: Frey, Sarah, et al.
Publicado: (2022)

Denomination "beam transformer”
por: Battisti, S
Publicado: (1971)

Comment on “The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis”
por: Minamino, Hiroto, et al.
Publicado: (2022)

Offline: The origin story—towards a final resolution?
por: Horton, Richard
Publicado: (2022)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

Ensuring continued progress for development of COVID-19 therapeutics in children
por: Noel, Gary J., et al.
Publicado: (2021)

Reply to the comment on “Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students”
por: Knitza, Johannes, et al.
Publicado: (2022)

Handbook of denominations in the United States
por: Mead, Frank Spencer, 1898-
Publicado: (1995)

Final approval for corticosteroids in severe CAP? For sure, in septic shock
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Implications of COVID-19 for patients with pre-existing digestive diseases
por: Mao, Ren, et al.
Publicado: (2020)

Trust is the common denominator for COVID-19 vaccine acceptance: A literature review
por: Adhikari, Bipin, et al.
Publicado: (2022)

Can alternative nicotine products put the final nail in the smoking coffin?
por: Fagerström, Karl
Publicado: (2022)

Implications of COVID-19 for patients with pre-existing digestive diseases: an update
por: Mao, Ren, et al.
Publicado: (2021)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

Oxidative stress: the lowest common denominator of multiple diseases
por: Matschke, Veronika, et al.
Publicado: (2019)

Diagnosis of acute rheumatic carditis: An echo in time…
por: Karthikeyan, Ganesan
Publicado: (2012)

COVID-19 vaccines and kidney disease
por: Windpessl, Martin, et al.
Publicado: (2021)

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey
por: D'Amico, Ferdinando, et al.
Publicado: (2020)

World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease
por: Pinto, Fausto J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_38b6eo3ql89f52ilfio2sb1ni2